NCT07294989 The Effective Blood Concentration of Ciprofol
| NCT ID | NCT07294989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Shenzhen Hospital |
| Condition | Thyroid Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 101 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 101 participants in total. It began in 2025-07-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
1. Eligible patients were selected and enrolled in the study. 2. General anesthesia was induced using ciprofol in all participants, with standardized evaluation of consciousness levels during induction. 3. The patients' pain and cognition are followed up after surgery.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-65 years * Scheduled for elective thyroidectomy * ASA physical status classification I-II * Willing to participate and providing written informed consent Exclusion Criteria: * Recent use of sedatives or opioid analgesics * Severe hepatic or renal dysfunction defined as:Child-Pugh class C (score ≥10), Creatinine clearance \<35 mL/min ,Requiring preoperative dialysis * Significant cardiovascular comorbidities * Body mass index ≥35 kg/m² or \<18.5 kg/m² * Known hypersensitivity or adverse reactions to propofol/ciprofol * Neuropsychiatric disorders including:Alzheimer's disease,History of cerebrovascular events,Traumatic brain injury,Space-occupying brain lesions,Other significant neurological deficits
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07294989 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Thyroid Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07294989 currently recruiting?
Yes, NCT07294989 is actively recruiting participants. Contact the research team at 496855048@qq.com for enrollment information.
Where is the NCT07294989 trial being conducted?
This trial is being conducted at Shenzhen, China.
Who is sponsoring the NCT07294989 clinical trial?
NCT07294989 is sponsored by Peking University Shenzhen Hospital. The trial plans to enroll 101 participants.